{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:58:48Z","timestamp":1774051128776,"version":"3.50.1"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["U24DK098085"],"award-info":[{"award-number":["U24DK098085"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Transplantation of isolated human islets is a valuable therapy for individuals with severe type 1 diabetes. A shortage of suitable pancreata and islets hinders access to islet transplantation (IT). Organ donation after circulatory death (DCD) islets are believed inferior and not appropriate for clinical IT. We readdressed this and compared outcomes between DCD and standard-of-care donation after brain death (DBD) islets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>The data sample comprised 801 human islet isolations &gt;2 decades from a single IT center. Islets from DCD and DBD donor organs were compared for islet outcome and quality. In some instances, a noninferior equivalency analysis was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Across the study interval, islet yield, viability, and function remained high despite a deterioration in donor health biometrics. Noninferior analysis demonstrated that DCD islets were equivalent to DBD islets in islet yield post-culture and in murine diabetes reversion. In fact, in vivo islet function trended to more diabetes reversal in mice receiving DCD islets versus animals given DBD islets (75% versus 67%). As well, no significant differences were observed between groups in age, body mass index, pancreas cold ischemia time, digestion switch time, islet yield (success &gt;250\u2009000 islet equivalent), purity (&gt;80%), recovery (&gt;75%), post-culture viability, transplantable preparations, or insulin stimulation index. The median days of hospitalization and warm ischemia time were significantly greater in DCD versus the DBD group. Predictably, elevated donor hemoglobin A1c negatively impacted islet quality regardless of donation death status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Results from islet isolations &gt;2 decades from a single center are presented. DCD islets were found to be equivalent to DBD islets on several relevant metrics. These findings encourage wider use of DCD donor islets for clinical IT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001930","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:00:07Z","timestamp":1774047607000},"page":"e1930","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Donation After Circulatory Death Islets are Comparable to Standard-of-Care Donation After Brain Death Islets: Analysis of 801 Consecutive Human Islet Isolations"],"prefix":"10.1097","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8531-8733","authenticated-orcid":false,"given":"Meirigeng","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Omori","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Orr","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Valiente","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiela","family":"Bilbao","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Tucker","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Rawson","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Verret","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Cuadra","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Mares","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Jou","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doreen","family":"Ligot","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennie","family":"Balandran","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotake","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco, San Francisco, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miryam","family":"Mehra","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Ramos","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Hacker-Stratton","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail H.","family":"Al-Abdullah","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Isenberg","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."},{"name":"Department of Diabetes Complications & Metabolism, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Kandeel","sequence":"additional","affiliation":[{"name":"Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute, City of Hope National Medical Center, Duarte, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"R1-20260320","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ajt.13458","article-title":"Long-term follow-up of the Edmonton protocol of islet transplantation in the United States.","volume":"16","author":"Brennan","year":"2016","journal-title":"Am J Transplant"},{"key":"R2-20260320","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia.","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"R3-20260320","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2337\/dc17-1779","article-title":"Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia.","volume":"41","author":"Foster","year":"2018","journal-title":"Diabetes Care"},{"key":"R4-20260320","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.3389\/ti.2022.10507","article-title":"A worldwide survey of activities and practices in clinical islet of Langerhans transplantation.","volume":"35","author":"Berney","year":"2022","journal-title":"Transpl Int"},{"key":"R5-20260320","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jhbp.891","article-title":"Clinical islet transplantation: current progress and new frontiers.","volume":"28","author":"Marfil-Garza","year":"2021","journal-title":"J Hepatob Pancreat Sci"},{"key":"R6-20260320","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00592-014-0627-6","article-title":"Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience.","volume":"51","author":"Qi","year":"2014","journal-title":"Acta Diabetol"},{"key":"R7-20260320","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI200423235","article-title":"Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.","volume":"114","author":"Rother","year":"2004","journal-title":"J Clin Invest"},{"key":"R8-20260320","doi-asserted-by":"crossref","first-page":"1485444","DOI":"10.3389\/frtra.2024.1485444","article-title":"Status of islet transplantation and innovations to sustainable outcomes: novel sites, cell sources, and drug delivery strategies.","volume":"3","author":"Wong","year":"2024","journal-title":"Front Transplant"},{"key":"R9-20260320","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1600-6143.2009.02758.x","article-title":"Time to cardiac death after withdrawal of life-sustaining treatment in potential organ donors.","volume":"9","author":"Suntharalingam","year":"2009","journal-title":"Am J Transplant"},{"key":"R10-20260320","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.transproceed.2014.06.006","article-title":"Long-term outcomes of clinical transplantation of pancreatic islets with uncontrolled donors after cardiac death: a multicenter experience in Japan.","volume":"46","author":"Anazawa","year":"2014","journal-title":"Transplant Proc"},{"key":"R11-20260320","doi-asserted-by":"crossref","first-page":"E109","DOI":"10.1152\/ajpendo.00310.2021","article-title":"Considerations and challenges of islet transplantation and future therapies on the horizon.","volume":"322","author":"Walker","year":"2022","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R12-20260320","doi-asserted-by":"crossref","first-page":"E362","DOI":"10.1152\/ajpendo.00443.2014","article-title":"Sodium levels of human pancreatic donors are a critical factor for determination of islet efficacy and survival.","volume":"308","author":"Qi","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 1","key":"R13-20260320","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/diab.38.1.S140","article-title":"Automated islet isolation from human pancreas.","volume":"38","author":"Ricordi","year":"1989","journal-title":"Diabetes"},{"key":"R14-20260320","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00007890-200012270-00014","article-title":"First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer.","volume":"70","author":"Kauffman","year":"2000","journal-title":"Transplantation"},{"key":"R15-20260320","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00125-019-4876-3","article-title":"The Integrated Islet Distribution Program answers the call for improved human islet phenotyping and reporting of human islet characteristics in research articles.","volume":"62","author":"Brissova","year":"2019","journal-title":"Diabetologia"},{"key":"R16-20260320","first-page":"341","article-title":"One hundred human pancreatic islet isolations at Baylor Research Institute.","volume":"23","author":"Takita","year":"2010","journal-title":"Proc"},{"key":"R17-20260320","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1600-6143.2009.02962.x","article-title":"Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes.","volume":"10","author":"Kaddis","year":"2010","journal-title":"Am J Transplant"},{"key":"R18-20260320","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11892-011-0217-8","article-title":"State of the art of clinical islet transplantation and novel protocols of immunosuppression.","volume":"11","author":"Shapiro","year":"2011","journal-title":"Curr Diab Rep"},{"key":"R19-20260320","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3727\/096368914X683548","article-title":"Human pancreatic islets isolated from donors with elevated HbA1c levels: islet yield and graft efficacy.","volume":"24","author":"Qi","year":"2015","journal-title":"Cell Transplant"},{"key":"R20-20260320","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1038\/s41598-019-45678-y","article-title":"Pancreatic human islets and insulin-producing cells derived from embryonic stem cells are rapidly identified by a newly developed Dithizone.","volume":"9","author":"Khiatah","year":"2019","journal-title":"Sci Rep"},{"key":"R21-20260320","doi-asserted-by":"crossref","first-page":"e0258434","DOI":"10.1371\/journal.pone.0258434","article-title":"Chronic marijuana usage by human pancreas donors is associated with impaired islet function.","volume":"16","author":"Qi","year":"2021","journal-title":"PLoS One"},{"key":"R22-20260320","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajt.2023.10.001","article-title":"A scalable human islet 3D-culture platform maintains cell mass and function long-term for transplantation.","volume":"24","author":"Omori","year":"2024","journal-title":"Am J Transplant"},{"key":"R23-20260320","doi-asserted-by":"crossref","first-page":"9636897211052291","DOI":"10.1177\/09636897211052291","article-title":"A multiparametric assessment of human islets predicts transplant outcomes in diabetic mice.","volume":"30","author":"Komatsu","year":"2021","journal-title":"Cell Transplant"},{"key":"R24-20260320","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.transproceed.2004.04.055","article-title":"Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients.","volume":"36","author":"Gaber","year":"2004","journal-title":"Transplant Proc"},{"key":"R25-20260320","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/TP.0b013e31817ef846","article-title":"Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation.","volume":"86","author":"Caiazzo","year":"2008","journal-title":"Transplantation"},{"key":"R26-20260320","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/TP.0b013e31820ae48e","article-title":"Quantification of the islet product: presentation of a standardized current good manufacturing practices compliant system with minimal variability.","volume":"91","author":"Friberg","year":"2011","journal-title":"Transplantation"},{"key":"R27-20260320","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.2337\/db16-0234","article-title":"National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: manufacture of a complex cellular product at eight processing facilities.","volume":"65","author":"Ricordi","year":"2016","journal-title":"Diabetes"},{"key":"R28-20260320","doi-asserted-by":"crossref","first-page":"9636897211057130","DOI":"10.1177\/09636897211057130","article-title":"Towards a rational balanced pancreatic and islet allocation schema.","volume":"30","author":"Kandeel","year":"2021","journal-title":"Cell Transplant"},{"key":"R29-20260320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2047-1440-2-12","article-title":"Extended pancreas donor program\u2014the EXPAND study rationale and study protocol.","volume":"2","author":"Proneth","year":"2013","journal-title":"Transplant Res"},{"key":"R30-20260320","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00125-005-1725-3","article-title":"Islet isolation for allotransplantation: variables associated with successful islet yield and graft function.","volume":"48","author":"Nano","year":"2005","journal-title":"Diabetologia"},{"key":"R31-20260320","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/TP.0b013e3181683df5","article-title":"Donor and isolation variables predicting human islet isolation success.","volume":"85","author":"Hanley","year":"2008","journal-title":"Transplantation"},{"key":"R32-20260320","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/096368970901805-610","article-title":"Estimation of donor usability for islet transplantation in the United States with the kyoto islet isolation method.","volume":"18","author":"Matsumoto","year":"2009","journal-title":"Cell Transplant"},{"key":"R33-20260320","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/TP.0b013e318247281b","article-title":"A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products.","volume":"93","author":"Balamurugan","year":"2012","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"R34-20260320","first-page":"23","article-title":"Body mass index of pancreatic donors: a decisive factor for human islet isolation.","volume":"103","author":"Brandhorst","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R35-20260320","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/MPA.0000000000001541","article-title":"High fractions of large islets in human islet preparations detrimentally affect posttransplant outcomes in streptozotocin-induced diabetic immunodeficient mice.","volume":"49","author":"Komatsu","year":"2020","journal-title":"Pancreas"},{"issue":"Suppl 1","key":"R36-20260320","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"34","author":"American Diabetes","year":"2011","journal-title":"Diabetes Care"},{"key":"R37-20260320","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.2337\/db14-1303","article-title":"Summary of the Keystone islet workshop (April 2014): the increasing demand for human islet availability in diabetes research.","volume":"63","author":"Kulkarni","year":"2014","journal-title":"Diabetes"},{"key":"R38-20260320","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/19382014.2017.1417716","article-title":"Evaluation of collagenase gold plus BP protease in isolating islets from human pancreata.","volume":"10","author":"Khiatah","year":"2018","journal-title":"Islets"},{"key":"R39-20260320","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/TXD.0000000000000522","article-title":"The choice of enzyme for human pancreas digestion is a critical factor for increasing the success of islet isolation.","volume":"1","author":"Qi","year":"2015","journal-title":"Transplant Direct"},{"key":"R40-20260320","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/labinvest.2010.124","article-title":"Quantitative analysis of cell composition and purity of human pancreatic islet preparations.","volume":"90","author":"Pisania","year":"2010","journal-title":"Lab Invest"},{"key":"R41-20260320","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s13300-025-01732-9","article-title":"Cell therapy for T1D beyond BLA: gearing up toward clinical practice.","volume":"16","author":"Wang","year":"2025","journal-title":"Diabetes Ther"},{"key":"R42-20260320","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/tri.12681","article-title":"Utilization of organs from donors after circulatory death for vascularized pancreas and islet of Langerhans transplantation: recommendations from an expert group.","volume":"29","author":"Berney","year":"2016","journal-title":"Transpl Int"},{"key":"R43-20260320","doi-asserted-by":"crossref","first-page":"e0251055","DOI":"10.1371\/journal.pone.0251055","article-title":"Lower beta cell yield from donor pancreases after controlled circulatory death prevented by shortening acirculatory warm ischemia time and by using IGL-1 cold preservation solution.","volume":"16","author":"De Paep","year":"2021","journal-title":"PLoS One"},{"key":"R44-20260320","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1111\/ajt.16691","article-title":"Warm ischemia time influences human islet cell isolation yield when assessed as beta cell number but not as islet equivalent number.","volume":"21","author":"De Paep","year":"2021","journal-title":"Am J Transplant"},{"key":"R45-20260320","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1111\/ajt.16533","article-title":"Clinical use of donation after circulatory death pancreas for islet transplantation.","volume":"21","author":"Doppenberg","year":"2021","journal-title":"Am J Transplant"},{"key":"R46-20260320","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ajt.2024.09.034","article-title":"Abdominal normothermic regional perfusion after donation after circulatory death improves pancreatic islet isolation yield.","volume":"25","author":"Doppenberg","year":"2025","journal-title":"Am J Transplant"},{"key":"R47-20260320","doi-asserted-by":"crossref","first-page":"e1667","DOI":"10.1097\/TXD.0000000000001667","article-title":"Evaluating islet cell isolation and transplantation from donors following medical assistance in dying.","volume":"10","author":"Parente","year":"2024","journal-title":"Transplant Direct"},{"key":"R48-20260320","doi-asserted-by":"crossref","first-page":"9636897221096160","DOI":"10.1177\/09636897221096160","article-title":"Utility of islet cell preparations from donor pancreases after euthanasia.","volume":"31","author":"De Paep","year":"2022","journal-title":"Cell Transplant"},{"key":"R49-20260320","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/SLA.0000000000006876","article-title":"Long-term Follow-up after hypothermic oxygenated machine perfusion in DCD liver transplantation: results of a randomized controlled multicenter trial (DHOPE-DCD).","volume":"282","author":"van Rijn","year":"2025","journal-title":"Ann Surg"},{"key":"R50-20260320","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.3389\/ti.2025.14807","article-title":"The individual impact of machine perfusion on liver and kidney on donor expansion in simultaneous liver and kidney transplantation.","volume":"38","author":"Oki","year":"2025","journal-title":"Transpl Int"},{"key":"R51-20260320","doi-asserted-by":"crossref","first-page":"ezaf315","DOI":"10.1093\/ejcts\/ezaf315","article-title":"Impact of donation after circulatory death heart transplantation on clinical outcomes after listing for heart transplantation.","volume":"67","author":"Duehmke","year":"2025","journal-title":"Eur J Cardiothorac Surg"},{"key":"R52-20260320","doi-asserted-by":"crossref","first-page":"1176398","DOI":"10.3389\/frtra.2023.1176398","article-title":"Pancreas transplantation with grafts obtained from donation after cardiac death or donation after brain death results in comparable outcomes.","volume":"2","author":"Bleszynski","year":"2023","journal-title":"Front Transplant"},{"key":"R53-20260320","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db20-0297","article-title":"Building biomimetic potency tests for islet transplantation.","volume":"70","author":"Glieberman","year":"2021","journal-title":"Diabetes"},{"key":"R54-20260320","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MPA.0000000000001050","article-title":"Impact of oxygen on pancreatic islet survival.","volume":"47","author":"Komatsu","year":"2018","journal-title":"Pancreas"},{"key":"R55-20260320","doi-asserted-by":"crossref","first-page":"12402","DOI":"10.1038\/s41598-024-61604-3","article-title":"Biological hypoxia in pre-transplant human pancreatic islets induces transplant failure in diabetic mice.","volume":"14","author":"Kato","year":"2024","journal-title":"Sci Rep"},{"key":"R56-20260320","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.3727\/096368912X653273","article-title":"The islet size to oxygen consumption ratio reliably predicts reversal of diabetes posttransplant.","volume":"21","author":"Pepper","year":"2012","journal-title":"Cell Transplant"},{"key":"R57-20260320","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.1152\/ajpendo.00221.2022","article-title":"Thrombospondin-1, CD47, and SIRPalpha display cell-specific molecular signatures in human islets and pancreata.","volume":"324","author":"Erdem","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R58-20260320","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvv243","article-title":"HIF-2alpha-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction.","volume":"109","author":"Labrousse-Arias","year":"2016","journal-title":"Cardiovasc Res"},{"key":"R59-20260320","doi-asserted-by":"crossref","first-page":"38923","DOI":"10.1074\/jbc.M110.172304","article-title":"Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.","volume":"285","author":"Kaur","year":"2010","journal-title":"J Biol Chem"},{"key":"R60-20260320","doi-asserted-by":"crossref","first-page":"26069","DOI":"10.1074\/jbc.M605040200","article-title":"CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.","volume":"281","author":"Isenberg","year":"2006","journal-title":"J Biol Chem"},{"key":"R61-20260320","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.kint.2016.03.034","article-title":"CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion.","volume":"90","author":"Rogers","year":"2016","journal-title":"Kidney Int"},{"key":"R62-20260320","doi-asserted-by":"crossref","first-page":"eadd2387","DOI":"10.1126\/scitranslmed.add2387","article-title":"A metabolic role for CD47 in pancreatic beta cell insulin secretion and islet transplant outcomes.","volume":"15","author":"Ghimire","year":"2023","journal-title":"Sci Transl Med"},{"key":"R63-20260320","doi-asserted-by":"crossref","first-page":"9636897241310989","DOI":"10.1177\/09636897241310989","article-title":"Shorter digestion times of donor islets is associated with better islet graft function after islet transplantation.","volume":"34","author":"Wang","year":"2025","journal-title":"Cell Transplant"},{"key":"R64-20260320","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3727\/096368916X691141","article-title":"A multicenter study: North American islet donor score in donor pancreas selection for human islet isolation for transplantation.","volume":"25","author":"Wang","year":"2016","journal-title":"Cell Transplant"},{"key":"R65-20260320","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3727\/096368912X657332","article-title":"Histidine-tryptophan-ketoglutarate and University of Wisconsin solution demonstrate equal effectiveness in the preservation of human pancreata intended for islet isolation: a large-scale, single-center experience.","volume":"22","author":"Paushter","year":"2013","journal-title":"Cell Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:00:25Z","timestamp":1774047625000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001930","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"2025-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}